XAnge
Guilhem de Vregille has been a Partner at XAnge for 15 years, a key investor in Europe with € 450 M under management and a portfolio of 55 startups. In addition to XAnge, Guilhem is an Investor & board member at Qubit Pharmaceuticals, RIOTS, TreeFrog Therapeutics, Aerospacelab, Wandercraft, Elum Energy, POLLEN Metrology, and Mdoloris Medical Systems. Guilhem is also a former Investor & board member at Sparklane. Guilhem studied at emlyon business school and ECAM LaSalle.